chr10-27100268-T-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014915.3(ANKRD26):c.59A>T(p.Gln20Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q20R) has been classified as Benign.
Frequency
Consequence
NM_014915.3 missense
Scores
Clinical Significance
Conservation
Publications
- thrombocytopenia 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
 - acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - autosomal thrombocytopenia with normal plateletsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 34 
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF:  0.00  AC: 0AN: 1458412Hom.:  0  Cov.: 86 AF XY:  0.00  AC XY: 0AN XY: 725570 
GnomAD4 genome  Cov.: 34 
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at